Suppr超能文献

乙醛在人体血液中的分布:乙醇及双硫仑治疗的影响

Distribution of acetaldehyde in human blood: effects of ethanol and treatment with disulfiram.

作者信息

Helander A, Löwenmo C, Johansson M

机构信息

Karolinska Institute, Department of Psychiatry, St Göran's Hospital, Stockholm, Sweden.

出版信息

Alcohol Alcohol. 1993 Jul;28(4):461-8.

PMID:8397528
Abstract

The distribution of free and bound acetaldehyde in human blood was studied. Fresh whole blood was precipitated with a perchloric acid (PCA) in saline solution and an aliquot of the crude sample was taken for determination of 'total' acetaldehyde. The remaining sample was centrifuged and the clear supernatant taken for analysis of 'soluble' acetaldehyde. 'Bound' acetaldehyde was calculated by subtracting soluble from total amounts. In samples collected from healthy control subjects, the acetaldehyde level in separated plasma was usually below the limit of detection of the method (0.2 microM), while much higher concentrations (> 2.5 microM) were detected when analyses were carried out on whole blood. In whole blood, about 70% was recovered as bound (i.e. PCA-insoluble) acetaldehyde. The soluble (i.e. free + PCA-soluble) level was higher than that found in separated plasma, suggesting that some acetaldehyde was liberated from the blood cells by PCA treatment. In blood spiked with ethanol, a spontaneous formation of acetaldehyde occurred during the analytical procedure. The artefactual formation increased only the soluble amount, while the bound level remained unchanged. Likewise, in samples drawn from intoxicated subjects, artefactual formation of acetaldehyde was observed in the soluble fraction, while the bound amount was not significantly increased. No significant differences in acetaldehyde levels were found between males and females, nor between healthy control subjects and alcoholic patients undergoing treatment with the aldehyde dehydrogenase inhibitor disulfiram (Antabuse). However, some of the Antabuse patients possessed elevated levels of bound acetaldehyde.

摘要

对人体血液中游离和结合态乙醛的分布进行了研究。用生理盐水配制的高氯酸(PCA)沉淀新鲜全血,取一份粗样品测定“总”乙醛。将剩余样品离心,取清澈的上清液分析“可溶性”乙醛。“结合”乙醛通过从总量中减去可溶性乙醛来计算。在从健康对照受试者采集的样本中,分离血浆中的乙醛水平通常低于该方法的检测限(0.2微摩尔),而对全血进行分析时检测到的浓度要高得多(>2.5微摩尔)。在全血中,约70%以结合态(即PCA不溶性)乙醛形式回收。可溶性(即游离+PCA可溶性)水平高于分离血浆中的水平,这表明PCA处理使血细胞释放出了一些乙醛。在加有乙醇的血液中,分析过程中会自发形成乙醛。人为形成的乙醛仅增加了可溶性乙醛的量,而结合态水平保持不变。同样,在从醉酒受试者采集的样本中,在可溶性部分观察到了人为形成的乙醛,而结合态的量没有显著增加。男性和女性之间、健康对照受试者与接受乙醛脱氢酶抑制剂双硫仑(安塔布司)治疗的酒精性患者之间,乙醛水平均未发现显著差异。然而,一些服用双硫仑的患者结合态乙醛水平升高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验